JP2017149718A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017149718A5 JP2017149718A5 JP2017041298A JP2017041298A JP2017149718A5 JP 2017149718 A5 JP2017149718 A5 JP 2017149718A5 JP 2017041298 A JP2017041298 A JP 2017041298A JP 2017041298 A JP2017041298 A JP 2017041298A JP 2017149718 A5 JP2017149718 A5 JP 2017149718A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- disease
- antigens
- tumor
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US89142407P | 2007-02-23 | 2007-02-23 | |
| US60/891,424 | 2007-02-23 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015043527A Division JP6422797B2 (ja) | 2007-02-23 | 2015-03-05 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017149718A JP2017149718A (ja) | 2017-08-31 |
| JP2017149718A5 true JP2017149718A5 (https=) | 2017-11-09 |
Family
ID=39710782
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009550629A Pending JP2010518834A (ja) | 2007-02-23 | 2008-02-22 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
| JP2015043527A Expired - Fee Related JP6422797B2 (ja) | 2007-02-23 | 2015-03-05 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
| JP2017041298A Pending JP2017149718A (ja) | 2007-02-23 | 2017-03-06 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009550629A Pending JP2010518834A (ja) | 2007-02-23 | 2008-02-22 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
| JP2015043527A Expired - Fee Related JP6422797B2 (ja) | 2007-02-23 | 2015-03-05 | 樹状細胞のレクチン様酸化ｌｄｌ受容体−１（ｌｏｘ−１）を介したヒト抗原提示細胞の活性化 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US8481314B2 (https=) |
| EP (2) | EP2132226B1 (https=) |
| JP (3) | JP2010518834A (https=) |
| KR (1) | KR20090127886A (https=) |
| CN (1) | CN101668772A (https=) |
| AU (1) | AU2008218190C1 (https=) |
| BR (1) | BRPI0807563A2 (https=) |
| CA (1) | CA2715919C (https=) |
| IL (1) | IL200529A0 (https=) |
| MX (1) | MX2009008919A (https=) |
| NZ (2) | NZ579257A (https=) |
| TW (2) | TWI440468B (https=) |
| WO (1) | WO2008103953A2 (https=) |
| ZA (1) | ZA200906620B (https=) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI422594B (zh) | 2007-02-02 | 2014-01-11 | Baylor Res Inst | 經由樹狀細胞去唾液酸糖蛋白受體（ｄｃ-ａｓｇｐｒ）接合抗原呈現細胞之藥劑 |
| FR2955773B1 (fr) | 2010-02-01 | 2017-05-26 | Commissariat Energie Atomique | Complexe moleculaire de ciblage des antigenes vers les cellules presentatrices d'antigene et ses applications pour la vaccination |
| BR112012028522A2 (pt) | 2010-05-07 | 2016-07-19 | Baylor Res Inst | sensibilização cruzada mediada por imunorreceptores de células dendríticas (dcir) de células t humanas cd8+ |
| CA2884430A1 (en) * | 2012-09-07 | 2014-03-13 | Baylor Research Institute | Hiv vaccine compositions and methods |
| UY35620A (es) | 2013-06-21 | 2015-01-30 | Novartis Ag | Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso |
| AR096601A1 (es) | 2013-06-21 | 2016-01-20 | Novartis Ag | Anticuerpos del receptor 1 de ldl oxidado similar a lectina y métodos de uso |
| CN105555303A (zh) | 2013-06-28 | 2016-05-04 | 贝勒研究院 | 用于多发性硬化症的树突细胞asgpr靶向免疫治疗剂 |
| CN120939216A (zh) | 2014-01-13 | 2025-11-14 | 贝勒研究院 | 抗hpv和hpv相关的疾病的新疫苗 |
| AR099812A1 (es) | 2014-03-21 | 2016-08-17 | Abbvie Inc | Anticuerpos y conjugados de anticuerpo y fármaco anti-egfr |
| WO2015175957A1 (en) | 2014-05-16 | 2015-11-19 | Baylor Research Institute | Methods and compositions for treating autoimmune and inflammatory conditions |
| CN108064243B (zh) | 2014-10-01 | 2021-08-27 | 免疫医疗有限公司 | 对lox1具有特异性的结合蛋白及其用途 |
| US11073521B2 (en) | 2015-06-01 | 2021-07-27 | The Wistar Institute Of Anatomy And Biology | Methods for monitoring polymorphonuclear myeloid derived suppressor cells |
| RU2021120719A (ru) * | 2015-09-30 | 2021-11-03 | Медиммьюн Лимитед | Композиции и способы подавления раковых стволовых клеток |
| WO2017214322A1 (en) | 2016-06-08 | 2017-12-14 | Abbvie Inc. | Anti-b7-h3 antibodies and antibody drug conjugates |
| MX2018015285A (es) | 2016-06-08 | 2019-09-18 | Abbvie Inc | Anticuerpos anti-b7-h3 y conjugados de anticuerpo y farmaco. |
| JP2019524651A (ja) | 2016-06-08 | 2019-09-05 | アッヴィ・インコーポレイテッド | 抗ｃｄ９８抗体及び抗体薬物コンジュゲート |
| AU2017279550A1 (en) | 2016-06-08 | 2019-01-03 | Abbvie Inc. | Anti-B7-H3 antibodies and antibody drug conjugates |
| EP3554544A4 (en) | 2016-12-16 | 2020-07-29 | Bluefin Biomedicine, Inc. | ANTI-PROTEIN 1 ANTIBODY CONTAINING AN ANTI-CUB DOMAIN (CDCP1), ANTIBODY-DRUG CONJUGATES AND THEIR METHODS OF USE |
| EP3612567B1 (en) | 2017-04-19 | 2024-09-11 | Bluefin Biomedicine, Inc. | Anti-vtcn1 antibodies and antibody drug conjugates |
| CA3066918A1 (en) | 2017-06-12 | 2018-12-20 | Bluefin Biomedicine, Inc. | Anti-il1rap antibodies and antibody drug conjugates |
| AR124681A1 (es) | 2021-01-20 | 2023-04-26 | Abbvie Inc | Conjugados anticuerpo-fármaco anti-egfr |
| CN114657121B (zh) * | 2022-03-23 | 2023-07-25 | 新乡医学院 | LOX1基因作为流体剪切力作用下BMSCs成骨分化促进剂的应用 |
| WO2025027529A1 (en) | 2023-07-31 | 2025-02-06 | Advesya | Anti-il-1rap antibody drug conjugates and methods of use thereof |
| CN119119263B (zh) * | 2023-10-08 | 2025-02-14 | 安徽千诚生物技术有限公司 | 一种pct蛋白抗体、定量检测pct蛋白的胶乳增强免疫比浊试剂盒及其制备 |
| TW202530255A (zh) | 2023-12-15 | 2025-08-01 | 法商亞維西亞有限公司 | 抗ｉｌ－１ｒａｐ結合結構域及其抗體－藥物偶聯物 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL154600B (nl) * | 1971-02-10 | 1977-09-15 | Organon Nv | Werkwijze voor het aantonen en bepalen van specifiek bindende eiwitten en hun corresponderende bindbare stoffen. |
| US3949064A (en) | 1973-10-26 | 1976-04-06 | Baxter Laboratories, Inc. | Method of detecting antigens or antibodies |
| US4174384A (en) * | 1975-06-30 | 1979-11-13 | Syva Company | Fluorescence quenching with immunological pairs in immunoassays |
| US4554101A (en) | 1981-01-09 | 1985-11-19 | New York Blood Center, Inc. | Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity |
| US20040258688A1 (en) * | 1995-01-31 | 2004-12-23 | Daniel Hawiger | Enhanced antigen delivery and modulation of the immune response therefrom |
| US6046158A (en) * | 1996-12-20 | 2000-04-04 | Board Of Regents The University Of Texas Systems | Unique dendritic cell-associated C-type lectins, dectin-1 and dectin-2; compositions and uses thereof |
| US6541011B2 (en) | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
| US5945308A (en) * | 1998-04-03 | 1999-08-31 | Incyte Pharmaceuticals, Inc. | Human oxidized LDL receptor |
| CA2401993A1 (en) * | 2000-03-02 | 2001-09-07 | Abgenix, Inc. | Human monoclonal antibodies against oxidized ldl receptor and pharmaceutical uses thereof |
| US20030166277A1 (en) * | 2000-04-12 | 2003-09-04 | University Of Rochester | Targeted vaccine delivery systems |
| FR2816060A1 (fr) * | 2000-10-27 | 2002-05-03 | Pf Medicament | Procede d'identification de nouvelles molecules se liant au recepteur lox et utilisation de ces molecules |
| JP2004236504A (ja) * | 2003-02-03 | 2004-08-26 | Toyota Central Res & Dev Lab Inc | 酵素配列複合体及び固定化酵素配列複合体とそれらの製造方法、担体分子及び酵素 |
| CA2572133A1 (en) * | 2004-06-25 | 2006-01-12 | Medimmune, Inc. | Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis |
| US7666596B2 (en) * | 2005-05-23 | 2010-02-23 | University Of Alberta | Tissue rejection |
-
2008
- 2008-02-22 EP EP08730569.4A patent/EP2132226B1/en active Active
- 2008-02-22 BR BRPI0807563-8A patent/BRPI0807563A2/pt not_active IP Right Cessation
- 2008-02-22 JP JP2009550629A patent/JP2010518834A/ja active Pending
- 2008-02-22 MX MX2009008919A patent/MX2009008919A/es active IP Right Grant
- 2008-02-22 EP EP19150601.3A patent/EP3489260B1/en active Active
- 2008-02-22 CA CA2715919A patent/CA2715919C/en active Active
- 2008-02-22 AU AU2008218190A patent/AU2008218190C1/en active Active
- 2008-02-22 WO PCT/US2008/054792 patent/WO2008103953A2/en not_active Ceased
- 2008-02-22 KR KR1020097019443A patent/KR20090127886A/ko not_active Ceased
- 2008-02-22 CN CN200880013222A patent/CN101668772A/zh active Pending
- 2008-02-22 US US12/036,138 patent/US8481314B2/en active Active
- 2008-02-22 TW TW097106300A patent/TWI440468B/zh active
- 2008-02-22 NZ NZ579257A patent/NZ579257A/en unknown
- 2008-02-22 NZ NZ589341A patent/NZ589341A/en unknown
- 2008-02-22 TW TW100119316A patent/TWI556826B/zh active
-
2009
- 2009-08-20 IL IL200529A patent/IL200529A0/en unknown
- 2009-09-22 ZA ZA200906620A patent/ZA200906620B/xx unknown
-
2013
- 2013-06-26 US US13/927,437 patent/US9339556B2/en active Active
-
2015
- 2015-03-05 JP JP2015043527A patent/JP6422797B2/ja not_active Expired - Fee Related
-
2017
- 2017-03-06 JP JP2017041298A patent/JP2017149718A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017149718A5 (https=) | ||
| Rappuoli et al. | Vaccines, new opportunities for a new society | |
| Sztein et al. | Complex adaptive immunity to enteric fevers in humans: lessons learned and the path forward | |
| CY1116407T1 (el) | Εμβολιο | |
| RU2007127993A (ru) | Сахарид-конъюгатные вакцины | |
| CN108770357B (zh) | 聚合物结合疫苗 | |
| JP2017523180A5 (https=) | ||
| WO2007081447A8 (en) | Norovirus and sapovirus antigens | |
| Keshavan et al. | An update of clinical experience with the quadrivalent meningococcal ACWY-CRM conjugate vaccine | |
| JP2016040284A5 (https=) | ||
| WO2009000825A3 (en) | Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates | |
| TWI850197B (zh) | 免疫原性組成物 | |
| WO2011156774A3 (en) | Multivalent glycopeptide constructs and uses thereof | |
| CN103083652A (zh) | 一种以异型双功能试剂为连接桥的脑膜炎多糖结合疫苗及其制备方法 | |
| JP2022130637A5 (https=) | ||
| Pettigrew et al. | Panel 6: vaccines | |
| WO2003085098A3 (en) | Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti | |
| Baker et al. | Childhood vaccine development: an overview | |
| Di Pietro et al. | Meningococcal disease in pediatric age: a focus on epidemiology and prevention | |
| Pelton et al. | Panel 6: vaccines | |
| Omoniyi et al. | Designing a multi-epitope vaccine against the Lassa virus through reverse vaccinology, subtractive proteomics, and immunoinformatics approaches | |
| JP2018501322A5 (https=) | ||
| JP2015522272A5 (https=) | ||
| JP2007535492A5 (https=) | ||
| JP2016528176A5 (https=) |